Acute ischemic cerebrovascular disease management quality of care following the adoption of the angels initiative

Calidad de atención en el manejo de enfermedad cerebrovascular isquémica aguda posterior a la iniciativa angels

Main Article Content

Lady Katherine Anzola Rincón
Claudia Marcela Moreno
Astrid Stefanny Anzola Rincón
Miguel Arturo Silva Soler
Hernán Mauricio Patiño
Ana María Valentierra Ramírez
Luisa Fernanda Gómez Montoya

Abstract

Introduction: cerebrovascular attack (CVA) is common worldwide. One in four people may have a stroke during their lifetime. It is the second leading cause of death and the third leading cause of disability. Thus, it is important to provide integrated care to achieve an impact on quality of life. Objective: to determine ischemic CVA management quality of care among patients seen at the neurology service of the San José and Infantil Universitario de San José hospitals in Bogotá DC, between January 1/2019 and January 1/2020.   Methodology: a descriptive, cross-sectional study. The inclusion criteria included patients over 18 years of age diagnosed with ischemic CVA. Information was collected from clinical records. Data was analyzed using descriptive statistics. Results: 411 patients were included; 88.8% had an altered state of consciousness, 26.4% were admitted within the 4.5-hour window for thrombolysis; 11.4% underwent intravenous reperfusion procedures. Door-to-needle time: median was 37.2 minutes versus the national media of 56.5 min according to the ResQ records platform; 72% received anti-platelet therapy and 88.8% received statins. Discussion and conclusions: the establishment of a strict time to care and the implementation of platforms to improve care plans, is essential. Massive education campaigns are required, as well as, institutional improvement plans.

Keywords:

Downloads

Download data is not yet available.

Article Details

Author Biographies

Astrid Stefanny Anzola Rincón, Fundación Universitaria de Ciencias de la Salud

Residente I de Medicina Interna, Fundación Universitaria de Ciencias de la Salud.

Ana María Valentierra Ramírez, Fundación Universitaria de Ciencias de la Salud

Estudiante de Medicina, Semilleros de Investigación Fundación Universitaria de Ciencias de la Salud.

References

Campbell BCV, Khatri P. Stroke. Lancet. 2020;396(10244):129-42. https://doi.org/10.1016/S0140-6736(20)31179-X DOI: https://doi.org/10.1016/S0140-6736(20)31179-X

Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, Parmar PG, et al. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. N Engl J Med. 2018;379(25):2429-37. https://doi.org/10.1056/NEJMoa1804492 DOI: https://doi.org/10.1056/NEJMoa1804492

Herpich F, Rincon F. Management of Acute Ischemic Stroke. Critical Care Medicine. 2020;48(11):1654-1663. https://doi.org/10.1097/CCM.0000000000004597 DOI: https://doi.org/10.1097/CCM.0000000000004597

Rabinstein A. Update on Treatment of Acute Ischemic Stroke. Continuum (Minneap Minn). 2020;26(2):268-286. https://doi.org/10.1212/CON.0000000000000840

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418. https://doi.org/10.1161/STR.0000000000000211 DOI: https://doi.org/10.1161/STR.0000000000000211

Mendelson SJ,Prabhakaran S. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. JAMA 2021 Mar 16;325(11):1088-1098. https://doi.org/10.1001/jama.2020.26867 DOI: https://doi.org/10.1001/jama.2020.26867

Montaño A, Hanley DF, Hemphill C. Hemorrhagic stroke. Handbook of Clinical Neurology. 2021;176:229-248. https://doi.org/10.1016/B978-0-444-64034-5.00019-5 DOI: https://doi.org/10.1016/B978-0-444-64034-5.00019-5

Pandian JD, Gall SL, Kate MP, Silva GS, Akinyemi RO, Ovbiagele BI, et al. Prevention of stroke: a global perspective. Lancet. 2018;392(10154):1269-78. https://doi.org/10.1016/S0140-6736(18)31269-8 DOI: https://doi.org/10.1016/S0140-6736(18)31269-8

Feske S. Ischemic Stroke. The American Journal of Medicine. 2021 Dec;134(12):1457-1464. https://doi.org/10.1016/j.amjmed.2021.07.027 DOI: https://doi.org/10.1016/j.amjmed.2021.07.027

Powers WJ. Acute Ischemic Stroke. N Engl J Med. 2020;383(3):252-60. https://doi.org/10.1056/NEJMcp1917030 DOI: https://doi.org/10.1056/NEJMcp1917030

Rabinstein AA. Update on Treatment of Acute Ischemic Stroke. Continuum (Minneap Minn). 2020;26(2):268-86. https://doi.org/10.1212/CON.0000000000000840 DOI: https://doi.org/10.1212/CON.0000000000000840

Jolugbo P, Ariëns AS. Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke. Stroke. 2021;52(3):1131-1142. https://doi.org/10.1161/STROKEAHA.120.032810 DOI: https://doi.org/10.1161/STROKEAHA.120.032810

Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci. 2020;21(20). https://doi.org/10.3390/ijms21207609 DOI: https://doi.org/10.3390/ijms21207609

Katan M, Luft A. Global Burden of Stroke. Semin Neurol. 2018;38(2):208-11. https://doi.org/10.1055/s-0038-1649503 DOI: https://doi.org/10.1055/s-0038-1649503

Gurol ME. Secondary Stroke Prevention in Atrial Fibrillation: New Insights Into an Old Problem. Stroke. 2018;49(6):1315-7. https://doi.org/10.1161/STROKEAHA.118.021262 DOI: https://doi.org/10.1161/STROKEAHA.118.021262

Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, et al. Ischaemic stroke. Nat Rev Dis Primers. 2019;5(1):70. https://doi.org/10.1038/s41572-019-01188 DOI: https://doi.org/10.1038/s41572-019-0118-8

Guo Y, Lane DA, Wang L, Zhang H, Wang H, Zhang W, et al. Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation. J Am Coll Cardiol. 2020;75(13):1523-34. https://doi.org/10.1016/j.jacc.2020.01.052 DOI: https://doi.org/10.1016/j.jacc.2020.01.052

Moreno E, Rodríguez J, Bayona-Ortiz H. Trombólisis endovenosa como tratamiento del ACV isquémico agudo en Colombia: una revisión sistemática de la literatura. Acta Neurol Colomb. 2019;35(3):156-66. https://doi.org/10.22379/24224022262 DOI: https://doi.org/10.22379/24224022262

Schwarzbach C J, Eichner F A, Pankert A, et al,. Stroke aftercare : Treatment reality, challenges and future perspectives. Nervenarzt. 2020;91(6):477-483. https://doi.org/10.1007/s00115-020-00909-w DOI: https://doi.org/10.1007/s00115-020-00909-w

Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ. 2020;368:l6983. https://doi.org/10.1136/bmj.l6983 DOI: https://doi.org/10.1136/bmj.l6983

Saini V, Guada L, Yavagal DR. Global Epidemiology of Stroke and Access to Acute Ischemic Stroke Interventions. Neurology. 2021;97(20 Suppl 2):S6-S16. https://doi.org/10.1212/WNL.0000000000012781 DOI: https://doi.org/10.1212/WNL.0000000000012781

McMeekin P, White P, James MA, Price CI, Flynn D, Ford GA. Estimating the number of UK stroke patients eligible for endovascular thrombectomy. Eur Stroke J. 2017;2(4):319-26. https://doi.org/10.1177/2396987317733343 DOI: https://doi.org/10.1177/2396987317733343

Marganska V. Stroke Rehabilitation: Therapy Robots and Assistive Devices. Adv Exp Med Biol. 2018;1065:579-587. https://doi.org/10.1007/978-3-319-77932-4_35 DOI: https://doi.org/10.1007/978-3-319-77932-4_35

Joundi R, Menon B. Thrombus Composition, Imaging, and Outcome Prediction in Acute Ischemic Stroke.Neurology. 2021 Nov 16;97(20 Suppl 2):S68-S78. https://doi.org/10.1212/WNL.0000000000012796 DOI: https://doi.org/10.1212/WNL.0000000000012796

Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383(14):1305-16. https://doi.org/10.1056/NEJMoa2019422 DOI: https://doi.org/10.1056/NEJMoa2019422

Dharmakidari S, Bhattacharya P, Chaturvedi S. Carotid Artery Stenosis: Medical Therapy, Surgery, and Stenting. Curr Neurol Neurosci Rep. 2017;17(10):77. https://doi.org/10.1007/s11910-017-0786-2 DOI: https://doi.org/10.1007/s11910-017-0786-2

Ibeh C, Elkind SV. Stroke Prevention After Cryptogenic Stroke. Current Cardiology Reports. 2021;23(12):174. https://doi.org/10.1007/s11886-021-01604-1 DOI: https://doi.org/10.1007/s11886-021-01604-1

Flach C, Muruet W, Wolfe C, et al,. Risk and Secondary Prevention of Stroke Recurrence: A Population-Base Cohort Study. Stroke. 2020;51(8):2435-2444. https://doi.org/10.1161/STROKEAHA.120.028992 DOI: https://doi.org/10.1161/STROKEAHA.120.028992

Aznaouridis K, Masoura C, Vlachopoulos C, Tousoulis D. Statins in Stroke. Curr Med Chem. 2019;26(33):6174-85. https://doi.org/10.2174/0929867326666190620104539 DOI: https://doi.org/10.2174/0929867326666190620104539

Caprio FZ, Sorond FA. Cerebrovascular Disease: Primary and Secondary Stroke Prevention. Med Clin North Am. 2019;103(2):295-308. https://doi.org/10.1016/j.mcna.2018.10.001 DOI: https://doi.org/10.1016/j.mcna.2018.10.001

Citado por